Production (Stage)
Genocea Biosciences, Inc.
GNCAQ
$0.00
$0.000.00%
OTC PK
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -37.19M | -33.20M | -34.90M | -35.83M | -42.84M |
| Total Depreciation and Amortization | 876.00K | 857.00K | 820.00K | 734.00K | 643.00K |
| Total Amortization of Deferred Charges | 700.00K | 700.00K | 600.00K | 600.00K | 600.00K |
| Total Other Non-Cash Items | -14.86M | -15.90M | -13.05M | -11.74M | -1.97M |
| Change in Net Operating Assets | 2.28M | 2.17M | 2.63M | 5.39M | 3.32M |
| Cash from Operations | -48.19M | -45.37M | -43.91M | -40.84M | -40.25M |
| Capital Expenditure | -3.14M | -3.29M | -3.72M | -3.86M | -3.46M |
| Sale of Property, Plant, and Equipment | 37.00K | 80.00K | 69.00K | 73.00K | 79.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.10M | -3.21M | -3.66M | -3.79M | -3.38M |
| Total Debt Issued | 0.00 | 10.00M | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -2.50M | -15.23M | -14.01M | -14.04M | -14.07M |
| Issuance of Common Stock | 7.89M | 11.57M | 13.23M | 87.34M | 87.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -377.00K | -377.00K | -377.00K | -377.00K |
| Cash from Financing | 5.39M | 5.96M | 8.85M | 82.92M | 83.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.90M | -42.62M | -38.72M | 38.29M | 39.53M |